✉news BusinessMarkets first seen 23 h ago, last 23 h ago, peak #36
Bristol-Myers Squibb Seen as Undervalued Dividend Play
Original: Bristol-Myers Squibb: The Market May Be Too Pessimistic About This 4-Star Dividend Stock
Morningstar argues the market may be too pessimistic about Bristol-Myers Squibb, rating the pharmaceutical company a 4-star stock and pointing to its dividend as attractive at current valuations. Investors are weighing whether concerns over patent expirations and pipeline risk have pushed the shares below their fair value.
Why now: Investors are debating whether the drugmaker's shares are undervalued amid worries about its growth outlook.
Bristol-Myers SquibbMorningstar
Evidence
- Bristol-Myers Squibb: The Market May Be Too Pessimistic About This 4-Star Dividend Stock · Morningstar
API: https://socialmediatrends-api.osmike.com/v1/trends/3984382